glp 1 agonist news Researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity Are Serious Anesthesia Risks of

For diabetic patients, this poses a substantial threat, as corticosteroids are known to induce hyperglycemia [34]

Bethel MA, Patel RA, Thompson VP, et al

Class 2: Alogliptin and linagliptin are targeted at specific areas: S1, S2, and sometimes S1` and S2 ` , Comparatively, linagliptin is almost eight times stronger than alogliptin [7], [8], [17], [20]

Wojcik C, Warden BA

3,5 In early T2DM managed with lifestyle alone, orforglipron lowered glycated hemoglobin A1c (HbA1c) by -1.24 to -1.48 percentage points over 40 weeks as compared to -0.41 with placebo, with no severe hypoglycemia reported and weight reduction ranging from 4.5% to 7.6%, 3 which led to mean HbA1c levels of 6.5-6.7%